Andrea Papadia1, Maria Luisa Gasparri2,3, Franziska Siegenthaler2, Sara Imboden2, Stefan Mohr2, Michael D Mueller2. 1. Department of Obstetrics and Gynecology, University Hospital of Berne, University of Berne, Effingerstrasse 102, 3010, Bern, Switzerland. andrea.papadia@insel.ch. 2. Department of Obstetrics and Gynecology, University Hospital of Berne, University of Berne, Effingerstrasse 102, 3010, Bern, Switzerland. 3. Department of Gynecology and Obstetrics, "Sapienza" University of Rome, Rome, Italy.
Abstract
PURPOSE: To compare two surgical strategies used to identify lymph node metastases in patients with preoperative diagnosis of complex atypical hyperplasia (CAH), grade 1 and 2 endometrial cancer (EC). METHODS: Data on patients with preoperative diagnosis of CAH, grade 1 and 2 EC undergoing laparoscopic indocyanine green (ICG) sentinel lymph node (SLN) mapping followed by frozen section of the uterus were collected. When risk factors were identified at frozen section, patients were subjected to a systematic lymphadenectomy. False negative (FN) rates, negative predictive values (NPV), positive predictive values (PPV) and correlation with stage IIIC EC were calculated for the systematic lymphadenectomy based on frozen section of the uterus and for the SLN mapping. RESULTS: Six (9.5%) out of 63 patients had lymph nodal metastases. Based on frozen section of the uterus, 22 (34.9%) and 15 (22.2%) patients underwent a pelvic and a pelvic and paraaortic lymphadenectomy, respectively. Five patients with stage IIIC disease were identified with a FN rate of 16.7% and a NPV and PPV of 97.6 and 27.3%, respectively. Overall and bilateral detection rates of ICG SLN mapping were 100 and 97.6%, respectively; no FN were recorded. The identification of patients with stage IIIC disease with ICG SLN mapping showed a NPV and PPV of 100%. Correlation between indication to lymphadenectomy and stage IIIC disease was poor (κ = 0.244) when based on frozen section of the uterus and excellent (κ = 1) when based on SLN mapping. CONCLUSIONS: ICG SLN mapping reduces the number of unnecessary systematic lymphadenectomies and the risk of underdiagnosing patients with metastatic lymph nodes.
PURPOSE: To compare two surgical strategies used to identify lymph node metastases in patients with preoperative diagnosis of complex atypical hyperplasia (CAH), grade 1 and 2 endometrial cancer (EC). METHODS: Data on patients with preoperative diagnosis of CAH, grade 1 and 2 EC undergoing laparoscopic indocyanine green (ICG) sentinel lymph node (SLN) mapping followed by frozen section of the uterus were collected. When risk factors were identified at frozen section, patients were subjected to a systematic lymphadenectomy. False negative (FN) rates, negative predictive values (NPV), positive predictive values (PPV) and correlation with stage IIIC EC were calculated for the systematic lymphadenectomy based on frozen section of the uterus and for the SLN mapping. RESULTS: Six (9.5%) out of 63 patients had lymph nodal metastases. Based on frozen section of the uterus, 22 (34.9%) and 15 (22.2%) patients underwent a pelvic and a pelvic and paraaortic lymphadenectomy, respectively. Five patients with stage IIIC disease were identified with a FN rate of 16.7% and a NPV and PPV of 97.6 and 27.3%, respectively. Overall and bilateral detection rates of ICG SLN mapping were 100 and 97.6%, respectively; no FN were recorded. The identification of patients with stage IIIC disease with ICG SLN mapping showed a NPV and PPV of 100%. Correlation between indication to lymphadenectomy and stage IIIC disease was poor (κ = 0.244) when based on frozen section of the uterus and excellent (κ = 1) when based on SLN mapping. CONCLUSIONS:ICG SLN mapping reduces the number of unnecessary systematic lymphadenectomies and the risk of underdiagnosing patients with metastatic lymph nodes.
Authors: Ilary Ruscito; Maria Luisa Gasparri; Elena Ioana Braicu; Filippo Bellati; Luigi Raio; Jalid Sehouli; Michael D Mueller; Pierluigi Benedetti Panici; Andrea Papadia Journal: Ann Surg Oncol Date: 2016-05-09 Impact factor: 5.344
Authors: Sanjeev Kumar; Fabiola Medeiros; Sean C Dowdy; Gary L Keeney; Jamie N Bakkum-Gamez; Karl C Podratz; William A Cliby; Andrea Mariani Journal: Gynecol Oncol Date: 2012-08-29 Impact factor: 5.482
Authors: Edward J Tanner; Abdulrahman K Sinno; Rebecca L Stone; Kimberly L Levinson; Kara C Long; Amanda N Fader Journal: Gynecol Oncol Date: 2015-06-19 Impact factor: 5.482
Authors: Abdulrahman K Sinno; Elizabeth Peijnenburg; Amanda N Fader; Sarah M Temkin; Rebecca Stone; Kimberly Levinson; Tricia Murdock; Edward J Tanner Journal: Gynecol Oncol Date: 2016-08-24 Impact factor: 5.482
Authors: Andrea Papadia; Sara Imboden; Maria Luisa Gasparri; Franziska Siegenthaler; Anja Fink; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2016-06-18 Impact factor: 4.553
Authors: Andrea Papadia; Sara Imboden; Franziska Siegenthaler; Maria Luisa Gasparri; Stefan Mohr; Susanne Lanz; Michael D Mueller Journal: Ann Surg Oncol Date: 2016-01-20 Impact factor: 5.344
Authors: Maria Luisa Gasparri; Donatella Caserta; Pierluigi Benedetti Panici; Andrea Papadia; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2018-11-20 Impact factor: 4.553
Authors: Andrea Papadia; Maria Luisa Gasparri; Alessandro Buda; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2017-08-21 Impact factor: 4.553
Authors: Brooke A Schlappe; Amy L Weaver; Jennifer A Ducie; Ane Gerda Zahl Eriksson; Sean C Dowdy; William A Cliby; Gretchen E Glaser; Robert A Soslow; Kaled M Alektiar; Vicky Makker; Nadeem R Abu-Rustum; Andrea Mariani; Mario M Leitao Journal: Gynecol Oncol Date: 2018-08-31 Impact factor: 5.482
Authors: Nicole Concin; Carien L Creutzberg; Ignace Vergote; David Cibula; Mansoor Raza Mirza; Simone Marnitz; Jonathan A Ledermann; Tjalling Bosse; Cyrus Chargari; Anna Fagotti; Christina Fotopoulou; Antonio González-Martín; Sigurd F Lax; Domenica Lorusso; Christian Marth; Philippe Morice; Remi A Nout; Dearbhaile E O'Donnell; Denis Querleu; Maria Rosaria Raspollini; Jalid Sehouli; Alina E Sturdza; Alexandra Taylor; Anneke M Westermann; Pauline Wimberger; Nicoletta Colombo; François Planchamp; Xavier Matias-Guiu Journal: Virchows Arch Date: 2021-02 Impact factor: 4.064
Authors: Andrea Papadia; Maria Luisa Gasparri; Anda P Radan; Chantal A L Stämpfli; Tilman T Rau; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2018-04-24 Impact factor: 4.553
Authors: Andrea Papadia; Alessandro Buda; Maria Luisa Gasparri; Giampaolo Di Martino; Beatrice Bussi; Debora Verri; Michael D Mueller Journal: J Cancer Res Clin Oncol Date: 2018-07-24 Impact factor: 4.553
Authors: A Santoro; A Piermattei; F Inzani; G Angelico; M Valente; D Arciuolo; S Spadola; M Martini; F Fanfani; A Fagotti; V Gallotta; G Scambia; G F Zannoni Journal: BMC Cancer Date: 2019-11-12 Impact factor: 4.430